existing major US, UK

AstraZeneca is a leading global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company primarily operates in three main therapy areas: Oncology, Cardiovascular, Renal & Metabolism (CVRM), and Respiratory & Immunology. Following the acquisition of Alexion Pharmaceuticals, it also established a dedicated unit for Rare Diseases. AstraZeneca is well-known for its extensive portfolio of blockbuster drugs, including Tagrisso, Farxiga, and Imfinzi, as well as its significant role in developing a widely used COVID-19 vaccine. Headquartered in Cambridge, UK, the company maintains a massive global footprint with major R&D and manufacturing hubs in the US, UK, and Sweden.